About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients

NCT02246777·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Alcon Research

Age

20–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of normal tension glaucoma.
Indicated for filtration surgery using Ex-PRESS®.
Understand and provide Informed Consent.

You may not be if

Women who are pregnant, lactating, or planning to be pregnant during the study period.
Diagnosis of angle closure glaucoma or secondary glaucoma.
History of glaucoma surgery.
Ophthalmologic surgery within the past 6 months.
Difficulty with applanation tonometry measurement.
Corneal dystrophy.
Infectious/non-infectious conjunctivitis, keratitis, or uveitis in either eye.
Severe blepharitis or dry eye.
History of metal allergy.

The record

StatusCompleted

PhaseNo phase

Taking part32

StartedFeb 2014

UpdatedJul 20, 2018

Conditions

Where1

Contact Alcon Japan, Ltd for Trial Locations
Tokyo, Japan

Clareo Health | Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients